Literature DB >> 17250435

Suppression of azoxymethane-induced colonic premalignant lesion formation by coenzyme Q10 in rats.

Katsuhisa Sakano1, Mami Takahashi, Mitsuaki Kitano, Takashi Sugimura, Keiji Wakabayashi.   

Abstract

Reactive oxygen species cause damage to proteins, lipids and DNA. Coenzyme Q10 (CoQ10) is a compound with mitochondrial bioenergetic functions. The reduced form of CoQ10 shows antioxidant activity. In the present study, effects of CoQ10 on development of azoxymethane (AOM)-induced aberrant crypt foci (ACF) and mucin-depleted foci (MDF) in F344 male rats were investigated. To induce ACF and MDF, 6-week old rats were given two weekly subcutaneous injections of AOM (15 mg/kg body weight) and also received a control diet or experimental diets containing CoQ10 (200 or 500 ppm) for 4 weeks, starting one day before the first dose of AOM. At 10 weeks of age, all animals were sacrificed and their colons were evaluated for numbers and sizes of ACF and MDF. Administration of 200 and 500 ppm CoQ10 resulted in reduction of ACF numbers, to 77% and 68% of the carcinogen control value, respectively. The percentages of ACF consisting of more than 4 crypts in these groups were also significantly lower than in the controls. Treatment with 500 ppm CoQ10 furthermore decreased the number of sialomucin-producing ACF and MDF per colon to 42% and 38% of the carcinogen control value without CoQ10, respectively. These results suggest that CoQ10 may be an effective chemopreventive agent against colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17250435

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

Authors:  Michael McCulloch; Michael Broffman; Mark van der Laan; Alan Hubbard; Lawrence Kushi; Donald I Abrams; Jin Gao; John M Colford
Journal:  Integr Cancer Ther       Date:  2011-09-30       Impact factor: 3.279

2.  Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3',4,4'-tetrachlorobiphenyl (PCB-77).

Authors:  Job C Tharappel; Hans-Joachim Lehmler; Cidambi Srinivasan; Larry W Robertson; Brett T Spear; Howard P Glauert
Journal:  Food Chem Toxicol       Date:  2008-08-30       Impact factor: 6.023

3.  Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort.

Authors:  Theodore M Brasky; Johanna W Lampe; John D Potter; Ruth E Patterson; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07       Impact factor: 4.254

4.  Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.

Authors:  Theodore M Brasky; Alan R Kristal; Sandi L Navarro; Johanna W Lampe; Ulrike Peters; Ruth E Patterson; Emily White
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

5.  Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial.

Authors:  Hsiao-Tien Liu; Yi-Chia Huang; Shao-Bin Cheng; Yin-Tzu Huang; Ping-Ting Lin
Journal:  Nutr J       Date:  2016-10-06       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.